Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects Devjit Tripathy , Priya Mohanty , Sandeep Dhindsa , Tufail Syed , Husam Ghanim , Ahmad Aljada and Paresh Dandona From the Division of Endocrinology, Diabetes and Metabolism, State University of New...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 52; no. 12; pp. 2882 - 2887 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.12.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
Devjit Tripathy ,
Priya Mohanty ,
Sandeep Dhindsa ,
Tufail Syed ,
Husam Ghanim ,
Ahmad Aljada and
Paresh Dandona
From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New
York
Address correspondence and reprint requests to Paresh Dandona, MD, PhD, Diabetes-Endocrinology Center of Western New York,
3 Gates Circle, Buffalo, NY 14209. E-mail: pdandona{at}kaleidahealth.org
Abstract
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA)
concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB)
binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and
polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured.
NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2
and 4 h ( P < 0.005) and remained elevated ( P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased
at 2, 4, and 6 h ( P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h ( P < 0.005), whereas that by MNCs increased at 4 h ( P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 ( P < 0.05) and 4 h ( P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased
from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% ( P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has
a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.
CRP, C-reactive protein
ELISA, enzyme-linked immunosorbent assay
FFA, free fatty acid
ICAM, intracellular adhesion molecule
IκB, inhibitor κB
IKK-β, IκB kinase-β
MCP-1, monocyte chemoattractant protein
MIF, macrophage migration inhibitory factor
MNC, mononuclear cell
NF-κB, nuclear factor-κB
PMN, polymorphonuclear leukocyte
ROS, reactive oxygen species
sICAM, soluble ICAM
TBARS, thiobarbituric acid reactive substances
TNF-α, tumor necrosis factor-α
Footnotes
Accepted September 12, 2003.
Received March 5, 2003.
DIABETES |
---|---|
AbstractList | Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
Devjit Tripathy ,
Priya Mohanty ,
Sandeep Dhindsa ,
Tufail Syed ,
Husam Ghanim ,
Ahmad Aljada and
Paresh Dandona
From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New
York
Address correspondence and reprint requests to Paresh Dandona, MD, PhD, Diabetes-Endocrinology Center of Western New York,
3 Gates Circle, Buffalo, NY 14209. E-mail: pdandona{at}kaleidahealth.org
Abstract
To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA)
concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB)
binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and
polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured.
NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2
and 4 h ( P < 0.005) and remained elevated ( P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased
at 2, 4, and 6 h ( P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h ( P < 0.005), whereas that by MNCs increased at 4 h ( P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 ( P < 0.05) and 4 h ( P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased
from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% ( P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has
a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.
CRP, C-reactive protein
ELISA, enzyme-linked immunosorbent assay
FFA, free fatty acid
ICAM, intracellular adhesion molecule
IκB, inhibitor κB
IKK-β, IκB kinase-β
MCP-1, monocyte chemoattractant protein
MIF, macrophage migration inhibitory factor
MNC, mononuclear cell
NF-κB, nuclear factor-κB
PMN, polymorphonuclear leukocyte
ROS, reactive oxygen species
sICAM, soluble ICAM
TBARS, thiobarbituric acid reactive substances
TNF-α, tumor necrosis factor-α
Footnotes
Accepted September 12, 2003.
Received March 5, 2003.
DIABETES To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-κB (NF-κB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-κB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-κB binding activity in the MNC nuclear extracts increased to 163 ± 17% and 144 ± 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-κB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 ± 1.1% at baseline to 4.3 ± 1.9% and 2.7 ± 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery. To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery. To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery.To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and heparin infusion for 4 h in 10 healthy subjects. We determined the nuclear factor-kappaB (NF-kappaB) binding activity in mononuclear cells (MNCs), the p65 subunit of NF-kappaB, reactive oxygen species (ROS) generation by MNC, and polymorphonuclear leukocytes (PMN). Brachial artery reactivity, using postischemic flow-mediated dilation, was also measured. NF-kappaB binding activity in the MNC nuclear extracts increased to 163 +/- 17% and 144 +/- 14% as compared with basal levels at 2 and 4 h (P < 0.005) and remained elevated (P < 0.05) at 6 h (2 h after cessation of lipid infusion). NF-kappaB p65 subunit protein expression in MNC homogenates also increased at 2, 4, and 6 h (P < 0.05). ROS generation by PMNs increased significantly at 2 and 4 h (P < 0.005), whereas that by MNCs increased at 4 h (P < 0.05). Plasma macrophage migration inhibitory factor increased at 2 (P < 0.05) and 4 h (P < 0.005), respectively, and declined to baseline at 6 h. The postischemic flow-mediated dilation of brachial artery decreased from 6.3 +/- 1.1% at baseline to 4.3 +/- 1.9% and 2.7 +/- 2.1% (P < 0.01) at 2, 4, and 6 h, respectively. We conclude that an increase in FFA concentration induces oxidative stress and has a proinflammatory effect; it also impairs postischemic flow-mediated vasodilation of the brachial artery. |
Audience | Professional |
Author | Priya Mohanty Tufail Syed Ahmad Aljada Devjit Tripathy Sandeep Dhindsa Husam Ghanim Paresh Dandona |
Author_xml | – sequence: 1 givenname: Devjit surname: Tripathy fullname: Tripathy, Devjit organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 2 givenname: Priya surname: Mohanty fullname: Mohanty, Priya organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 3 givenname: Sandeep surname: Dhindsa fullname: Dhindsa, Sandeep organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 4 givenname: Tufail surname: Syed fullname: Syed, Tufail organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 5 givenname: Husam surname: Ghanim fullname: Ghanim, Husam organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 6 givenname: Ahmad surname: Aljada fullname: Aljada, Ahmad organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York – sequence: 7 givenname: Paresh surname: Dandona fullname: Dandona, Paresh organization: From the Division of Endocrinology, Diabetes and Metabolism, State University of New York and Kaleida Health, Buffalo, New York |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15327899$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14633847$$D View this record in MEDLINE/PubMed |
BookMark | eNp90u-L0zAYB_AiJ97u9C8QpAgKgp350TbpyzHux2BwoIf4LmTJky0jbWeSnu6_N3M7jx3D5kWgfL6h6fO9yM66voMse4vRmFDKvmgrFxAhjCsyxmRMOCcvshFuaFNQwn6cZSOEMCkwa9h5dhHCGiFUp_UqO8dlTSkv2SgzVw4eZLR9l_cmv_YA-bWMcZtPlNUhn3V6ULDbjZNtu4ey0_ms3UjrQ_5dBjU46fOvIFW0DzZFbZffgnRxtc2_DYs1qBheZy-NdAHeHPbL7P766n56W8zvbmbTybxQdVXFwmAEaqFr4IQAVbpi0pQla7gy0ixQTRfKMKQJIUobyXhDJCk1Z5pwMCWil9nH_bEb3_8cIETR2qDAOdlBPwTBMG0qRMsE3z-D637wXfo0QXBdckxKllCxR0vpQNjO9NFLtYQOvHRpFsam1xOcnrLidZX8-IRPS0Nr1cnAp6NAMhF-x6UcQhD8Zn5si1NW9c7BEkT6i9O7Y__ucMNh0YIWG29b6bficfQJfDiANELpjJedsuHJValEvGmSa_ZO-T4ED0YoG_8WId3OOoGR2NVRPNZRVERgInZ1TFn6LPvv-P-mPu9TK7tc_bIentQp_gfRC_Kk |
CODEN | DIAEAZ |
CitedBy_id | crossref_primary_10_3390_nu13030742 crossref_primary_10_1007_s00018_011_0840_1 crossref_primary_10_1016_j_ypmed_2006_09_005 crossref_primary_10_1159_000443691 crossref_primary_10_1016_j_amjcard_2007_04_004 crossref_primary_10_1039_C8FO00888D crossref_primary_10_2147_CLEP_S313343 crossref_primary_10_18585_inabj_v5i2_58 crossref_primary_10_1111_j_1559_4572_2009_00054_x crossref_primary_10_2337_dc12_1912 crossref_primary_10_1016_j_obmed_2019_02_001 crossref_primary_10_3382_ps_2012_02723 crossref_primary_10_1016_j_amjcard_2023_07_010 crossref_primary_10_1016_j_biopha_2017_01_121 crossref_primary_10_1371_journal_pone_0172900 crossref_primary_10_1080_10641963_2019_1676771 crossref_primary_10_1111_j_1559_4572_2008_00013_x crossref_primary_10_1111_j_1600_051X_2010_01580_x crossref_primary_10_2337_dc17_2510 crossref_primary_10_1016_j_jdiacomp_2012_09_008 crossref_primary_10_1177_0022034509337479 crossref_primary_10_1016_j_metabol_2010_01_010 crossref_primary_10_1016_j_ajog_2011_03_044 crossref_primary_10_18585_inabj_v1i3_102 crossref_primary_10_1016_j_mce_2022_111836 crossref_primary_10_1007_s13679_016_0191_1 crossref_primary_10_1371_journal_pone_0016239 crossref_primary_10_1080_13880209_2018_1504972 crossref_primary_10_1073_pnas_0907995106 crossref_primary_10_2337_dc07_0817 crossref_primary_10_1155_2020_8683404 crossref_primary_10_1161_JAHA_115_002574 crossref_primary_10_3810_pgm_2013_07_2679 crossref_primary_10_1016_j_atherosclerosis_2005_06_045 crossref_primary_10_1016_j_mcna_2010_11_004 crossref_primary_10_1152_physiolgenomics_00196_2005 crossref_primary_10_4103_0366_6999_225058 crossref_primary_10_3892_ijmm_2023_5237 crossref_primary_10_12998_wjcc_v10_i26_9524 crossref_primary_10_1016_j_expneurol_2015_05_020 crossref_primary_10_1016_S1557_0843_09_80003_1 crossref_primary_10_1038_oby_2008_37 crossref_primary_10_1161_CIRCULATIONAHA_107_704080 crossref_primary_10_1038_oby_2008_39 crossref_primary_10_1186_s12937_025_01092_x crossref_primary_10_1097_MD_0000000000022465 crossref_primary_10_1007_BF03346417 crossref_primary_10_1007_s11695_018_3550_z crossref_primary_10_1530_JME_12_0166 crossref_primary_10_2337_dc09_S303 crossref_primary_10_1016_j_obpill_2022_100047 crossref_primary_10_1089_met_2004_2_287 crossref_primary_10_1186_cc3911 crossref_primary_10_2337_dc09_S304 crossref_primary_10_3390_nu7085292 crossref_primary_10_1111_j_1468_1331_2007_01682_x crossref_primary_10_1248_bpb_31_1415 crossref_primary_10_1038_s41598_020_73994_1 crossref_primary_10_1161_JAHA_121_022725 crossref_primary_10_1016_j_fluid_2021_113182 crossref_primary_10_2337_dc06_2289 crossref_primary_10_1089_ars_2023_0476 crossref_primary_10_1161_01_CIR_0000158483_13093_9D crossref_primary_10_1016_j_adengl_2012_08_024 crossref_primary_10_1038_s41385_021_00404_8 crossref_primary_10_2337_dc11_s240 crossref_primary_10_1007_s40778_021_00198_2 crossref_primary_10_1111_j_1600_051X_2011_01806_x crossref_primary_10_1155_2012_652608 crossref_primary_10_1161_ATVBAHA_107_153239 crossref_primary_10_1016_j_metabol_2004_04_005 crossref_primary_10_1016_j_hfc_2012_06_010 crossref_primary_10_4093_dmj_2012_36_2_83 crossref_primary_10_1038_s41574_023_00893_6 crossref_primary_10_1007_s00390_010_0220_3 crossref_primary_10_1016_j_mtadv_2021_100198 crossref_primary_10_1016_j_rvsc_2015_11_013 crossref_primary_10_3390_diabetology4020015 crossref_primary_10_1016_j_tips_2010_11_006 crossref_primary_10_1152_ajpendo_00187_2018 crossref_primary_10_1089_ars_2005_7_1040 crossref_primary_10_1097_01_smj_0000209366_91803_99 crossref_primary_10_2337_dbi16_0004 crossref_primary_10_3389_fendo_2020_607240 crossref_primary_10_1016_S0140_6736_05_66378_7 crossref_primary_10_1016_j_amjcard_2006_11_003 crossref_primary_10_1111_j_1365_2265_2005_02337_x crossref_primary_10_1152_ajpendo_00326_2005 crossref_primary_10_1016_j_bbrc_2007_01_039 crossref_primary_10_1111_j_1365_2265_2008_03519_x crossref_primary_10_1152_ajpendo_00490_2010 crossref_primary_10_2459_JCM_0000000000001046 crossref_primary_10_1096_fj_202000495RR crossref_primary_10_1016_S1001_9294_16_30025_6 crossref_primary_10_2337_dc09_S330 crossref_primary_10_1186_s12906_015_0598_3 crossref_primary_10_1089_met_2004_2_137 crossref_primary_10_1111_dom_12835 crossref_primary_10_1111_j_1742_4658_2007_05914_x crossref_primary_10_1002_jcb_22173 crossref_primary_10_1111_j_1872_034X_2009_00524_x crossref_primary_10_1016_j_jacl_2021_05_005 crossref_primary_10_2337_dc11_2399 crossref_primary_10_1515_hmbci_2018_0013 crossref_primary_10_1113_JP280651 crossref_primary_10_1186_s12986_017_0195_1 crossref_primary_10_1016_j_plefa_2010_02_012 crossref_primary_10_1111_j_2047_6310_2013_00189_x crossref_primary_10_1093_gerona_glt081 crossref_primary_10_3390_metabo15030184 crossref_primary_10_1016_j_atherosclerosis_2017_06_010 crossref_primary_10_2165_00003495_200464002_00004 crossref_primary_10_1016_j_jacl_2007_11_001 crossref_primary_10_1111_j_1463_1326_2004_00439_x crossref_primary_10_1177_1753944717711379 crossref_primary_10_1152_ajpendo_00566_2012 crossref_primary_10_1371_journal_pone_0130597 crossref_primary_10_1016_j_atherosclerosis_2011_09_005 crossref_primary_10_1161_CIRCULATIONAHA_108_780999 crossref_primary_10_1155_2016_5797930 crossref_primary_10_1016_j_ad_2012_08_003 crossref_primary_10_1038_srep05832 crossref_primary_10_1161_CIRCULATIONAHA_105_563213 crossref_primary_10_3390_nu14214640 crossref_primary_10_1016_j_animal_2022_100555 crossref_primary_10_1155_2016_1081657 crossref_primary_10_2337_db07_1344 crossref_primary_10_1016_j_atherosclerosis_2006_06_028 crossref_primary_10_1016_j_tripleo_2011_07_039 crossref_primary_10_1210_jc_2008_0714 crossref_primary_10_1111_j_1365_2362_2006_01734_x crossref_primary_10_1152_ajpendo_00202_2005 crossref_primary_10_3945_jn_112_163246 crossref_primary_10_1016_j_ajog_2015_05_040 crossref_primary_10_2337_db05_1574 crossref_primary_10_1016_j_maturitas_2013_02_006 crossref_primary_10_2337_db08_1077 crossref_primary_10_1074_jbc_M706762200 crossref_primary_10_3390_foods9030368 crossref_primary_10_1016_j_metabol_2012_03_006 crossref_primary_10_1038_nature05487 crossref_primary_10_3389_fnut_2021_775216 crossref_primary_10_3390_ani11061742 crossref_primary_10_1007_s00018_020_03752_z crossref_primary_10_1177_0961203312462756 crossref_primary_10_1016_j_atherosclerosis_2016_04_021 crossref_primary_10_1016_j_cmet_2020_12_017 crossref_primary_10_1152_ajpendo_00134_2005 crossref_primary_10_1016_j_adengl_2011_03_007 crossref_primary_10_1007_s40200_023_01367_2 crossref_primary_10_1016_S2222_1808_15_60888_X crossref_primary_10_3390_nu11112566 crossref_primary_10_1002_dmrr_634 crossref_primary_10_1007_s00125_006_0508_9 crossref_primary_10_1177_0963689719873890 crossref_primary_10_1016_j_krcp_2013_11_002 crossref_primary_10_1371_journal_pone_0281888 crossref_primary_10_1186_1478_1336_5_1 crossref_primary_10_1002_dmrr_509 crossref_primary_10_1089_ars_2022_0016 crossref_primary_10_1007_s00059_010_3344_0 crossref_primary_10_1016_j_rbmo_2012_06_004 crossref_primary_10_3390_ijms23073828 crossref_primary_10_1007_s00125_015_3663_z crossref_primary_10_1080_21688370_2024_2342619 crossref_primary_10_1016_j_clinbiochem_2019_01_008 crossref_primary_10_3390_metabo13070838 crossref_primary_10_1212_WNL_0000000000000275 crossref_primary_10_1002_ptr_2811 crossref_primary_10_1017_S0007114510004976 crossref_primary_10_1042_CS20110357 crossref_primary_10_1161_CIRCRESAHA_119_315833 crossref_primary_10_4103_ijmr_IJMR_1807_16 crossref_primary_10_1080_13880209_2020_1790619 crossref_primary_10_1016_j_cyto_2008_06_014 crossref_primary_10_1097_00042737_200411000_00001 crossref_primary_10_1161_CIR_0b013e3182a88099 crossref_primary_10_1016_j_metabol_2016_09_001 crossref_primary_10_1007_s11357_020_00313_x crossref_primary_10_1016_j_jphotobiol_2016_09_017 crossref_primary_10_1016_j_pcad_2014_09_005 crossref_primary_10_1590_0001_3765201920180547 crossref_primary_10_1152_ajpendo_00624_2006 crossref_primary_10_2337_db15_0244 crossref_primary_10_1152_ajpendo_00039_2017 crossref_primary_10_1111_j_1742_7843_2009_00448_x crossref_primary_10_1016_j_freeradbiomed_2012_05_026 crossref_primary_10_1155_2017_9067049 crossref_primary_10_1016_j_krcp_2015_01_001 crossref_primary_10_1002_oby_22602 crossref_primary_10_1038_ismej_2012_153 crossref_primary_10_3389_fendo_2022_854931 crossref_primary_10_1096_fj_08_124784 crossref_primary_10_1016_j_bbrc_2007_04_092 crossref_primary_10_1139_bcb_2022_0266 crossref_primary_10_1007_s00125_013_3111_x crossref_primary_10_5717_jenb_2014_18_1_51 crossref_primary_10_1532_HSF98_20101017 crossref_primary_10_1111_jgs_16793 crossref_primary_10_4158_EP12331_OR crossref_primary_10_1016_j_mehy_2014_08_018 crossref_primary_10_1016_j_diabet_2007_10_009 crossref_primary_10_1007_s00125_009_1573_7 crossref_primary_10_1155_2018_8168717 crossref_primary_10_1152_ajpheart_00038_2018 crossref_primary_10_1186_1476_511X_10_53 crossref_primary_10_1093_aje_kwac044 crossref_primary_10_18663_tjcl_687043 crossref_primary_10_1111_bcp_12854 crossref_primary_10_1155_2013_564961 crossref_primary_10_1111_acel_12416 crossref_primary_10_1111_j_1464_5491_2005_01656_x crossref_primary_10_1183_09031936_00050410 crossref_primary_10_1186_1475_2840_9_73 crossref_primary_10_1007_s11906_010_0114_6 crossref_primary_10_1016_j_jpeds_2007_03_056 crossref_primary_10_1016_j_metabol_2009_06_005 crossref_primary_10_1016_j_exger_2018_04_016 crossref_primary_10_1210_jendso_bvaa049 crossref_primary_10_1016_j_fct_2006_03_004 crossref_primary_10_1007_s11892_005_0064_6 crossref_primary_10_3390_antiox9070618 crossref_primary_10_1016_j_ecl_2017_10_005 crossref_primary_10_1016_j_ijcard_2010_07_019 crossref_primary_10_1016_j_lfs_2018_08_034 crossref_primary_10_1155_2015_202406 crossref_primary_10_2337_db10_0778 crossref_primary_10_1016_j_bbalip_2006_06_003 crossref_primary_10_1016_j_jhep_2005_10_033 crossref_primary_10_1155_2022_6007233 crossref_primary_10_1210_en_2006_1068 crossref_primary_10_1002_dmrr_70004 crossref_primary_10_1111_j_1440_1746_2010_06561_x crossref_primary_10_3389_fnhum_2020_602360 crossref_primary_10_3390_life14091082 crossref_primary_10_1053_j_gastro_2007_03_059 crossref_primary_10_1007_s40618_017_0799_3 crossref_primary_10_1053_j_ajkd_2020_11_030 crossref_primary_10_1016_j_freeradbiomed_2005_06_018 crossref_primary_10_1177_1753944707082662 crossref_primary_10_1016_j_vph_2015_05_006 crossref_primary_10_1111_dom_14206 crossref_primary_10_1371_journal_pone_0248073 crossref_primary_10_1007_s10237_017_1000_9 crossref_primary_10_3390_plants12203583 crossref_primary_10_3390_ani10091499 crossref_primary_10_1053_j_semtcvs_2006_06_003 crossref_primary_10_1016_S1557_0843_08_80035_8 crossref_primary_10_1016_j_soard_2011_09_026 crossref_primary_10_1038_s41387_024_00302_5 crossref_primary_10_1016_j_jacl_2020_06_005 crossref_primary_10_1002_jpen_2507 crossref_primary_10_1016_j_freeradbiomed_2004_12_010 crossref_primary_10_3810_psm_2014_02_2042 crossref_primary_10_1136_bmjopen_2018_028652 crossref_primary_10_1016_j_surg_2011_09_038 crossref_primary_10_1161_01_ATV_0000200226_53994_09 crossref_primary_10_1016_j_bbrc_2006_05_170 crossref_primary_10_1002_dmrr_1183 crossref_primary_10_1016_j_atherosclerosis_2009_10_032 crossref_primary_10_2337_dc15_1518 crossref_primary_10_1186_gm313 crossref_primary_10_1016_j_cimid_2011_01_004 crossref_primary_10_1186_s12865_016_0184_6 crossref_primary_10_3390_biomedicines13040779 crossref_primary_10_2337_dc10_0929 crossref_primary_10_1186_s12933_025_02599_7 crossref_primary_10_1152_ajpendo_00010_2005 crossref_primary_10_1210_jc_2009_1387 crossref_primary_10_1590_S0004_27302008000600007 crossref_primary_10_2337_dc07_1338 crossref_primary_10_1161_CIRCRESAHA_122_320334 crossref_primary_10_1042_BCJ20190468 crossref_primary_10_1038_oby_2010_291 crossref_primary_10_1507_endocrj_EJ16_0233 crossref_primary_10_1016_j_ahj_2004_03_060 crossref_primary_10_1210_jc_2005_0223 crossref_primary_10_1097_MCC_0b013e32826388a1 crossref_primary_10_1177_0003319710371616 crossref_primary_10_1002_bies_202400154 crossref_primary_10_3390_immuno4010006 crossref_primary_10_1210_en_2012_1720 crossref_primary_10_1016_j_smim_2015_05_002 crossref_primary_10_1111_ggi_14131 crossref_primary_10_1016_j_atherosclerosis_2020_12_016 crossref_primary_10_1161_CIRCHEARTFAILURE_113_000521 crossref_primary_10_1111_dom_13144 crossref_primary_10_1016_j_heliyon_2024_e30329 crossref_primary_10_1210_jc_2006_2491 crossref_primary_10_2337_db09_0232 crossref_primary_10_1016_j_nut_2007_10_018 crossref_primary_10_1016_j_cell_2013_01_041 crossref_primary_10_1210_jc_2006_2130 crossref_primary_10_1016_j_amjcard_2007_07_014 crossref_primary_10_1210_jc_2006_0195 crossref_primary_10_1136_bmjdrc_2018_000632 crossref_primary_10_1186_1472_6882_8_39 crossref_primary_10_1007_s00380_010_0016_1 crossref_primary_10_1161_01_CIR_0000142055_53122_FA crossref_primary_10_1002_biof_1277 crossref_primary_10_1038_s12276_018_0147_5 crossref_primary_10_1111_jphp_12223 crossref_primary_10_3892_mmr_2024_13219 crossref_primary_10_1517_14656566_6_13_2209 crossref_primary_10_1152_ajpendo_00300_2020 crossref_primary_10_1161_01_ATV_0000187465_55507_85 crossref_primary_10_1007_s11756_022_01112_9 crossref_primary_10_1016_j_metabol_2006_04_016 crossref_primary_10_1016_j_diabet_2010_12_005 crossref_primary_10_1017_S0029665111000073 crossref_primary_10_1038_ijo_2009_242 crossref_primary_10_3803_jkes_2006_21_6_448 crossref_primary_10_1016_j_diabres_2011_10_025 crossref_primary_10_1210_jc_2009_0027 crossref_primary_10_2147_DMSO_S264876 crossref_primary_10_1007_s00125_013_2964_3 crossref_primary_10_1111_eci_13737 crossref_primary_10_2337_dc14_1919 crossref_primary_10_1038_oby_2009_179 crossref_primary_10_2174_1871530323666230309144825 crossref_primary_10_1016_j_lfs_2013_05_002 crossref_primary_10_1155_2014_479587 crossref_primary_10_1155_2016_6757154 crossref_primary_10_1038_oby_2008_494 crossref_primary_10_1210_jc_2004_1795 crossref_primary_10_1016_j_freeradbiomed_2010_08_015 crossref_primary_10_1111_obr_13403 crossref_primary_10_1186_1475_2840_9_9 crossref_primary_10_2337_diacare_27_9_2272 crossref_primary_10_1210_jc_2008_1590 crossref_primary_10_3389_fphar_2020_588449 crossref_primary_10_1111_j_1365_2362_2004_01383_x crossref_primary_10_1155_2017_1909258 crossref_primary_10_1016_j_joms_2011_01_012 crossref_primary_10_1080_01480545_2024_2405830 crossref_primary_10_1038_s41598_023_28329_1 crossref_primary_10_1016_S0214_9168_08_72584_1 crossref_primary_10_3892_ijmm_2020_4479 crossref_primary_10_1016_j_arr_2024_102503 crossref_primary_10_1007_s00125_007_0861_3 crossref_primary_10_1371_journal_ppat_1004750 crossref_primary_10_2174_1871530322666220215110041 crossref_primary_10_1021_jf402966r crossref_primary_10_1111_j_1872_034X_2007_00215_x crossref_primary_10_1016_j_trsl_2021_05_006 crossref_primary_10_21215_kjfp_2022_12_3_144 crossref_primary_10_18632_oncotarget_26937 crossref_primary_10_1042_CS20080253 crossref_primary_10_1007_s13410_018_0626_1 crossref_primary_10_1007_s00592_008_0038_7 crossref_primary_10_1016_j_abb_2008_02_019 crossref_primary_10_2337_db08_1512 crossref_primary_10_1139_Y07_026 crossref_primary_10_18705_1607_419X_2008_14_2_116_124 crossref_primary_10_1089_met_2004_2_2 crossref_primary_10_1016_j_biopha_2018_08_129 crossref_primary_10_3109_15376516_2012_666648 crossref_primary_10_1126_sciadv_ads5963 crossref_primary_10_1007_s11892_010_0115_5 crossref_primary_10_2337_db14_1481 crossref_primary_10_1016_j_exer_2019_107737 crossref_primary_10_3390_ijms25126776 crossref_primary_10_1089_met_2004_2_105 crossref_primary_10_1016_j_ijbiomac_2007_11_002 crossref_primary_10_1007_s11940_015_0344_7 crossref_primary_10_1016_j_febslet_2014_09_024 crossref_primary_10_1177_0885066614528083 crossref_primary_10_1155_2015_620258 crossref_primary_10_1016_j_clineuro_2007_10_016 crossref_primary_10_2337_diacare_27_10_2509 crossref_primary_10_1053_j_jvca_2012_09_013 crossref_primary_10_18632_oncotarget_3202 crossref_primary_10_1016_j_amjcard_2014_06_012 crossref_primary_10_1093_bjd_ljac107 crossref_primary_10_1016_j_jnutbio_2009_03_004 crossref_primary_10_1007_s12020_023_03433_4 crossref_primary_10_1111_jdi_12678 crossref_primary_10_1074_jbc_M110_193037 crossref_primary_10_3390_biom13020241 crossref_primary_10_1111_j_1524_6175_2005_04617_x crossref_primary_10_3844_ajbbsp_2010_103_110 crossref_primary_10_2337_db08_1775 crossref_primary_10_1016_j_jcte_2015_02_004 crossref_primary_10_1161_01_CIR_0000165070_46111_9F crossref_primary_10_1016_j_ejphar_2013_05_014 crossref_primary_10_1210_jc_2012_1318 crossref_primary_10_12659_MSM_883206 crossref_primary_10_1016_j_ad_2011_03_010 crossref_primary_10_2337_dci21_0003 crossref_primary_10_3390_nu15020257 crossref_primary_10_1038_srep06697 crossref_primary_10_1186_s12920_020_00767_0 crossref_primary_10_1016_j_cca_2016_05_006 crossref_primary_10_1186_s12950_017_0150_y crossref_primary_10_1007_s11154_012_9235_3 crossref_primary_10_1007_s43440_019_00013_0 crossref_primary_10_1089_jmf_2014_3265 crossref_primary_10_1161_01_ATV_0000122852_22604_78 crossref_primary_10_1038_s41598_017_01603_9 crossref_primary_10_1007_s00125_021_05596_z crossref_primary_10_1210_jc_2012_1544 crossref_primary_10_3390_ph15101278 crossref_primary_10_1126_scitranslmed_3000850 crossref_primary_10_1186_1475_2840_10_61 crossref_primary_10_1016_j_atherosclerosis_2007_01_003 crossref_primary_10_1186_s12933_014_0159_y crossref_primary_10_1097_MCO_0b013e3281e38774 crossref_primary_10_1007_s12272_013_0023_8 crossref_primary_10_2174_1381612826666200203120540 crossref_primary_10_3390_ijms23020786 crossref_primary_10_1016_j_yfrne_2021_100972 crossref_primary_10_1096_fj_202300396R crossref_primary_10_1007_s11936_006_0045_3 crossref_primary_10_4081_pr_2009_e1 crossref_primary_10_1016_j_atherosclerosis_2010_05_028 crossref_primary_10_1210_er_2008_0024 crossref_primary_10_1016_j_yexcr_2017_05_020 crossref_primary_10_1007_s11154_012_9232_6 crossref_primary_10_1186_1472_6823_9_8 crossref_primary_10_3109_13813455_2011_562513 crossref_primary_10_1152_ajpendo_00507_2007 crossref_primary_10_1002_dmrr_1195 crossref_primary_10_1016_j_metabol_2010_02_005 crossref_primary_10_3390_metabo13010087 crossref_primary_10_1097_CCE_0000000000000977 crossref_primary_10_5402_2011_519371 crossref_primary_10_1016_j_prostaglandins_2020_106454 crossref_primary_10_1002_pmic_201000544 crossref_primary_10_1016_j_metabol_2006_06_001 crossref_primary_10_1530_JME_11_0082 crossref_primary_10_1111_jch_13443 crossref_primary_10_1016_j_diabres_2007_10_007 crossref_primary_10_1097_MOL_0b013e328012b627 crossref_primary_10_3390_antiox13010087 crossref_primary_10_1038_s41401_020_0493_4 crossref_primary_10_3390_nu14010203 crossref_primary_10_18705_1607_419X_2010_16_1_93_103 crossref_primary_10_1016_j_krcp_2014_10_007 crossref_primary_10_1017_S0029665107005320 crossref_primary_10_1186_s12979_018_0119_6 crossref_primary_10_1093_toxres_tfab014 crossref_primary_10_3390_nu11020384 crossref_primary_10_1152_physrev_00034_2018 crossref_primary_10_2337_diabetes_53_8_2079 crossref_primary_10_1038_mt_2016_160 crossref_primary_10_3389_fphar_2024_1364881 crossref_primary_10_1007_s11892_011_0190_2 crossref_primary_10_1016_j_jdiacomp_2006_10_009 crossref_primary_10_1111_j_1463_1326_2008_00867_x crossref_primary_10_1196_annals_1367_007 crossref_primary_10_1089_ars_2014_6126 crossref_primary_10_1016_j_bbrc_2008_08_115 crossref_primary_10_1002_fsn3_4 crossref_primary_10_3390_jcm9072257 crossref_primary_10_2337_dc10_2345 crossref_primary_10_1016_j_plipres_2021_101142 crossref_primary_10_1152_ajpheart_00291_2014 crossref_primary_10_1093_cvr_cvaa009 crossref_primary_10_1186_1743_7075_8_16 crossref_primary_10_1002_mco2_516 crossref_primary_10_1051_ject_201345242 crossref_primary_10_2174_0929867330666230510101150 |
Cites_doi | 10.1152/ajpregu.2000.279.3.R1043 10.1016/S0026-0495(98)90113-5 10.1084/jem.179.6.1895 10.1210/jcem.86.7.7623 10.1038/23948 10.1172/JCI5001 10.1007/s00125-002-0896-4 10.1126/science.1061620 10.1172/JCI118504 10.1210/jcem.86.3.7309 10.2337/diabetes.50.7.1612 10.1210/jc.86.7.3130 10.1172/JCI119636 10.1093/ajcp/97.4.566 10.1210/jc.86.7.3250 10.1172/JCI117936 10.4158/EP.7.1.44 10.1093/nar/19.9.2499 10.1161/01.CIR.96.10.3287 10.1210/jcem.83.8.5026 10.1385/0-89603-472-0:107 10.2337/diabetes.51.7.2005 10.1007/BF03401892 10.1042/bj2420103 10.1161/01.HYP.36.5.866 10.2337/diabetes.49.7.1231 10.2337/diabetes.48.6.1270 10.1073/pnas.95.19.11383 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS COPYRIGHT 2003 American Diabetes Association COPYRIGHT 2003 American Diabetes Association Copyright American Diabetes Association Dec 2003 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: COPYRIGHT 2003 American Diabetes Association – notice: COPYRIGHT 2003 American Diabetes Association – notice: Copyright American Diabetes Association Dec 2003 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8GL 3V. 7RV 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 LK8 M0R M0S M1P M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U S0X 7X8 |
DOI | 10.2337/diabetes.52.12.2882 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: High School ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest eLibrary (NC LIVE) ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database ProQuest Health & Medical Collection PML(ProQuest Medical Library) Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Research Library Prep MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 2887 |
ExternalDocumentID | 489990991 A111145865 14633847 15327899 10_2337_diabetes_52_12_2882 diabetes_52_12_2882 |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | - 08R 0R 1AW 29F 2WC 3V. 4.4 53G 55 5GY 5RE 5RS 5VS 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL 8R4 8R5 AAQQT AAWTL AAYEP AAYJJ ABFLS ABOCM ABPTK ABUWG ACDCL ACGOD ACPRK ADACO ADBBV ADBIT AENEX AFFNX AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BBAFP BBNVY BCR BCU BEC BENPR BES BHPHI BKEYQ BKNYI BLC BPHCQ BVXVI C1A CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EX3 F5P FRP FYUFA GICCO GJ GNUQQ GUQSH GX1 H13 HCIFZ HZ IAG IAO IEA IHR INH INR IOF IPO J5H K-O K9- KM KQ8 L7B LK8 M0R M1P M2O M2P M2Q M5 M7P MBDVC O0- O9- OB3 OBH OK1 OVD P2P PADUT PCD PEA PQEST PQQKQ PQUKI PRINS PROAC PSQYO Q2X RHF RHI RPM S0X SJFOW SJN SV3 TDI WH7 WOQ WOW X7M XZ ZA5 ZGI ZXP ZY1 --- .55 .GJ .XZ 08P 0R~ 18M 354 6PF AAFWJ AAKAS AAYOK AAYXX ACGFO ADZCM AEGXH AERZD AIAGR AIZAD ALIPV BTFSW CCPQU CITATION EMOBN HMCUK HZ~ ITC K2M M5~ N4W NAPCQ OHH PHGZM PHGZT TEORI TR2 UKHRP VVN W8F YFH YHG YOC ~KM 1CY ADGHP AI. H~9 IQODW MVM O5R O5S PJZUB PPXIY PQGLB VH1 XOL YQJ AFHIN CGR CUY CVF ECM EIF NPM PKN PMFND 7XB 8FK K9. PKEHL Q9U 7X8 |
ID | FETCH-LOGICAL-c655t-f10ecbd6e822e3cd57af44798cfafb063bcf70d222cdfa7892a24d87d28ef403 |
IEDL.DBID | 7X7 |
ISSN | 0012-1797 |
IngestDate | Fri Jul 11 12:25:05 EDT 2025 Fri Jul 25 19:29:12 EDT 2025 Fri Jun 13 00:47:09 EDT 2025 Tue Jun 10 21:25:03 EDT 2025 Fri Jun 27 04:10:54 EDT 2025 Tue Jun 10 19:06:25 EDT 2025 Wed Feb 19 02:32:51 EST 2025 Mon Jul 21 09:16:24 EDT 2025 Tue Jul 01 04:24:24 EDT 2025 Thu Apr 24 23:05:27 EDT 2025 Fri Jan 15 19:45:49 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Endocrinopathy Human Reactivity Diabetes mellitus Lipids Inflammation Free fatty acid |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c655t-f10ecbd6e822e3cd57af44798cfafb063bcf70d222cdfa7892a24d87d28ef403 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://diabetesjournals.org/diabetes/article-pdf/52/12/2882/371392/db1203002882.pdf |
PMID | 14633847 |
PQID | 216481247 |
PQPubID | 34443 |
PageCount | 6 |
ParticipantIDs | gale_incontextgauss_8GL_A111145865 proquest_journals_216481247 crossref_citationtrail_10_2337_diabetes_52_12_2882 gale_infotracgeneralonefile_A111145865 gale_incontextcollege_GICCO_A111145865 pascalfrancis_primary_15327899 highwire_diabetes_diabetes_52_12_2882 crossref_primary_10_2337_diabetes_52_12_2882 proquest_miscellaneous_71395034 gale_infotracacademiconefile_A111145865 pubmed_primary_14633847 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-12-01 |
PublicationDateYYYYMMDD | 2003-12-01 |
PublicationDate_xml | – month: 12 year: 2003 text: 2003-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2003 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | 2022031207073279900_R28 2022031207073279900_R27 2022031207073279900_R11 2022031207073279900_R10 2022031207073279900_R15 2022031207073279900_R14 2022031207073279900_R13 2022031207073279900_R12 2022031207073279900_R2 2022031207073279900_R19 2022031207073279900_R1 2022031207073279900_R18 2022031207073279900_R17 2022031207073279900_R16 2022031207073279900_R9 2022031207073279900_R8 2022031207073279900_R7 2022031207073279900_R6 2022031207073279900_R5 2022031207073279900_R4 2022031207073279900_R3 2022031207073279900_R22 2022031207073279900_R21 2022031207073279900_R20 2022031207073279900_R26 2022031207073279900_R25 2022031207073279900_R24 2022031207073279900_R23 |
References_xml | – ident: 2022031207073279900_R25 doi: 10.1152/ajpregu.2000.279.3.R1043 – ident: 2022031207073279900_R12 doi: 10.1016/S0026-0495(98)90113-5 – ident: 2022031207073279900_R27 doi: 10.1084/jem.179.6.1895 – ident: 2022031207073279900_R18 doi: 10.1210/jcem.86.7.7623 – ident: 2022031207073279900_R5 doi: 10.1038/23948 – ident: 2022031207073279900_R2 doi: 10.1172/JCI5001 – ident: 2022031207073279900_R26 doi: 10.1007/s00125-002-0896-4 – ident: 2022031207073279900_R6 doi: 10.1126/science.1061620 – ident: 2022031207073279900_R9 doi: 10.1172/JCI118504 – ident: 2022031207073279900_R24 doi: 10.1210/jcem.86.3.7309 – ident: 2022031207073279900_R1 doi: 10.2337/diabetes.50.7.1612 – ident: 2022031207073279900_R8 doi: 10.1210/jc.86.7.3130 – ident: 2022031207073279900_R3 doi: 10.1172/JCI119636 – ident: 2022031207073279900_R13 doi: 10.1093/ajcp/97.4.566 – ident: 2022031207073279900_R7 doi: 10.1210/jc.86.7.3250 – ident: 2022031207073279900_R10 doi: 10.1172/JCI117936 – ident: 2022031207073279900_R21 doi: 10.4158/EP.7.1.44 – ident: 2022031207073279900_R15 doi: 10.1093/nar/19.9.2499 – ident: 2022031207073279900_R28 doi: 10.1161/01.CIR.96.10.3287 – ident: 2022031207073279900_R11 doi: 10.1210/jcem.83.8.5026 – ident: 2022031207073279900_R16 doi: 10.1385/0-89603-472-0:107 – ident: 2022031207073279900_R23 doi: 10.2337/diabetes.51.7.2005 – ident: 2022031207073279900_R19 doi: 10.1007/BF03401892 – ident: 2022031207073279900_R14 doi: 10.1042/bj2420103 – ident: 2022031207073279900_R17 doi: 10.1161/01.HYP.36.5.866 – ident: 2022031207073279900_R4 doi: 10.2337/diabetes.49.7.1231 – ident: 2022031207073279900_R22 doi: 10.2337/diabetes.48.6.1270 – ident: 2022031207073279900_R20 doi: 10.1073/pnas.95.19.11383 |
SSID | ssj0006060 |
Score | 2.3548408 |
Snippet | Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects
Devjit Tripathy ,
Priya Mohanty ,
Sandeep Dhindsa ,... To test the possible acute proinflammatory effects of fatty acids, we induced an increase in plasma free fatty acid (FFA) concentrations after a lipid and... |
SourceID | proquest gale pubmed pascalfrancis crossref highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2882 |
SubjectTerms | Adult Anticoagulants Associated diseases and complications Biological and medical sciences Blood Brachial Artery - physiology Cytokines Diabetes Diabetes mellitus Diabetes research Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Fatty acid metabolism Fatty acids Fatty Acids, Nonesterified - blood Female Humans Inflammation Inflammation - etiology Insulin - blood Insulin resistance Kinases Leukocytes Lipids Male Medical sciences Monocytes - metabolism Neutrophils - metabolism NF-kappa B - metabolism Oxidative stress Physiological aspects Plasma Reactive Oxygen Species - metabolism Reference Values Thiobarbituric Acid Reactive Substances - metabolism Transcription Factor RelA Triglycerides - blood Tumor necrosis factor-TNF Vasodilation Veins & arteries |
Title | Elevation of Free Fatty Acids Induces Inflammation and Impairs Vascular Reactivity in Healthy Subjects |
URI | http://diabetes.diabetesjournals.org/content/52/12/2882.abstract https://www.ncbi.nlm.nih.gov/pubmed/14633847 https://www.proquest.com/docview/216481247 https://www.proquest.com/docview/71395034 |
Volume | 52 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglRAXxJtQWCwE5ULaxLFj54TKakuFaEGoSHuzHD-qSlW2bLKH_ntm1smuIpVedg-ZRHFmPP48nvmGkA-VrKuKCZ967sqUm7xMVW5sCpsJ42vlrFyHBk7PypM__PtczPvcnLZPqxx84tpRu4XFGPkhA1yPi5H8cv03xaZReLjad9C4T3aRuQyNWs43-60MsHmsQMkZsnDKSDrEikIeDoHNA8EwGsiUYqOFaXDPA2cwpkyaFr5aiO0u_o9H1-vS8WPyqAeU9ChawBNyzzdPyYPT_sj8GQmzKx_DrnQRaFh6T4Ppuhtq7KVrKWzJQbn4H8A2Yh0jNY2jWD55uWzpkKpKAV3a2GoChGmsn7yh7arGSE77nJwfz86nJ2nfXCG1pRBdGvLM29qVHhCCL6wT0gTOZaVsMKEG4FLbIDMH8MG6YKSqmGHcKemY8oFnxQuy0ywa_4pQFvJSYDi1tHBBSuVLmNWZqyVYAZc2IWz4sNr2xOPY_-JKwwYEtaEHbWjBdM40aiMhnzc3XUfejbvF91FjGhktGkyZsTHsomHI05_6CBcGLlQpEvJ-LHhhVm2r1bcfI6FPvVBYwJta05cqwHiRLWskuT-SvIhc4bcJfhxsafv-tw5kMjK07eBFgUXLVUL2BsvTvbtp9WZyJOTd5ir4CTz8MY1frFotAeqLrOAJeRnNdftkXhYFgJTXdz55jzyMeYyYyfOG7HTLlX8LeKyrJ-tZB79qmk_I7tfZ2a_f_wCkEjb5 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLfGkIAL4psw2CzExoWwxrHj5IDQVDY61o5LkXazHH9MlaZ0NK1Q_yf-SN6rk1aRxm479ZBXK877-X35fRDyoZBlUTDhYsdtFnOdZHGeaBODM6FdmVsjV6GB0Xk2-MV_XIiLLfK3rYXBtMpWJq4EtZ0ajJEfMrDrURnJr9e_YxwahZer7QSNgIozt_wDHlv95fQbsHefsZPjcX8QN0MFYpMJMY990nOmtJkDzehSY4XUnnNZ5MZrX4LCLo2XPQtq01ivZV4wzbjNpWW587yXwrL3yH2ewsHEuvT-JqEEXIFQ8JIwbPopQ48jBpSHbRz1s2AYfGR5zjp6sNUGbYtizNDUNTDJh-ka_zd_V2rw5Al53Niv9CgA7inZctUz8mDU3NA_J_74yoUoL5166mfOUa_n8yXVZmJrOqksYAl_PUAxlE1SXVmK1ZqTWU3bzFgKxqwJky2AmIZyzSWtFyUGjuoXZHwXn_0l2a6mlXtNKPNJJjB6mxl4IGXuMhAiPVtKAB2XJiKs_bDKNH3OcdzGlQJ_B7mhWm4owVTCFHIjIp_Wf7oObT5uJz9AjilsoFFhho4JUR4FW-7_VEeoh7jIMxGR913CS72oa5V_H3aIPjZEfgpvanRTGQH7xeZcHcqDDuVlaE1-E-F-i6XN-9-4kd0O0DabFynWSBcR2WmRpxrpVqv1WYzI3vopiCW8a9KVmy5qJcGzEL2UR-RVgOtmZZ6lKdhEb25deY88HIxHQzU8PT_bIY9CCiUmEb0l2_PZwr0DU3Be7q5OICXqjk_8P-Ckcok |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIlVcUHmbQrtCtFwwidde7_qAUJU2tPQBhyL1tlrvo4pUOW2cCOWf8fOYydqJLJXeesrBk5XX881jZ-dByMdClEXBuItdZvM400key0SbGA4T2pXSGrEIDZyd50e_sx-X_HKN_G1rYTCtstWJC0VtxwZj5D0Gfj0aI9HzTVbEr4Pht5vbGAdI4UVrO00jIOTEzf_A6a3-enwArN5lbHh4MTiKmwEDsck5n8Y-6TtT2tyBlXSpsVxon2WikMZrX4LxLo0XfQsm1FivhSyYZpmVwjLpfNZPYdlH5LFIhUQJk4NVcgkcC0LxS8KwAagI_Y5YmopeG1P9whkGIpmUrGMTW8vQtivGbE1dA8N8mLTxf1d4YRKHm-Rp48vS_QC-Z2TNVc_JxllzW_-C-MNrFyK-dOypnzhHvZ5O51Sbka3pqLKAK_z1AMtQQkl1ZSlWbo4mNW2zZCk4tiZMuQBiGko357SelRhEql-Si4f47K_IejWu3BtCmU9yjpHc3MADIaTLQaH0bSkAgJkwEWHth1Wm6XmOozeuFZx9kBuq5YbiTCVMITci8nn5p5vQ8uN-8j3kmMJmGhXi0oSIj4ItD36qfbRJGZc5j8iHLuGVntW1kt9PO0SfGiI_hjc1uqmSgP1io64O5V6H8iq0Kb-LcLfF0ur979zIdgdoq83zFOuli4hstchTjaar1VIuI7KzfAoqCu-ddOXGs1oJOGXwfppF5HWA62rlLE9T8I_e3rvyDtkAWVenx-cnW-RJyKbEfKJ3ZH06mbn34BVOy-2FAFKiHljg_wEfvna_ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevation+of+free+fatty+acids+induces+inflammation+and+impairs+vascular+reactivity+in+healthy+subjects&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Tripathy%2C+Devjit&rft.au=Mohanty%2C+Priya&rft.au=Dhindsa%2C+Sandeep&rft.au=Syed%2C+Tufail&rft.date=2003-12-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.volume=52&rft.issue=12&rft.spage=2882&rft_id=info:doi/10.2337%2Fdiabetes.52.12.2882&rft.externalDocID=A111145865 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |